Arora Satish, Andreassen Arne, Simonsen Svein, Gude Einar, Dahl Christen, Skaardal Rita, Hoel Ina, Geiran Odd, Gullestad Lars
Department of Cardiology, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway.
Transplantation. 2007 Jul 27;84(2):149-54. doi: 10.1097/01.tp.0000268810.61393.2c.
Impaired renal function is associated with increased mortality among heart failure patients. Although a significant proportion of heart transplant (HTx) recipients have reduced renal function at 1 year post-HTx, no previous study has evaluated the associated risk for both all-cause and cardiac mortality. Hence, we assessed the relationship between glomerular filtration rate (GFR) at 1 year post-HTx and all-cause and cardiac mortality and development of cardiac allograft vasculopathy (CAV).
We evaluated 381 patients with a minimum survival of 1 year post-HTx and the Modification of Diet in Renal Disease Study formula was used to calculate estimated GFR. Mortality and angiographic CAV were defined as separate endpoints, and median follow-up was 7.4 and 4.0 years, respectively.
During the follow-up period, 122 patients died and 154 patients developed CAV. Reduced GFR pre-HTx was not a risk factor for either endpoint. Overall, 193 (51%) patients had GFR <60 ml/min/1.73 m at one year post-HTx and this was an independent predictor of all-cause mortality with an adjusted hazard ratio of 1.7 (P=0.01) for a GFR between 30-60 and 3.2 (P=0.006) for GFR <30 ml/min/1.73 m. GFR <60 ml/min/1.73 m at 1 year post-HTx was also associated with a higher risk of cardiac mortality (HR=1.9; P=0.04) but did not predict the development of CAV.
Renal impairment is evident in a majority of HTx recipients at 1 year post-HTx. It is an important risk factor for both all-cause and cardiac mortality but does not predict the development of angiographic CAV.
肾功能受损与心力衰竭患者死亡率增加相关。尽管相当一部分心脏移植(HTx)受者在HTx术后1年肾功能下降,但此前尚无研究评估全因死亡率和心脏死亡率的相关风险。因此,我们评估了HTx术后1年肾小球滤过率(GFR)与全因死亡率、心脏死亡率以及心脏移植血管病变(CAV)发生之间的关系。
我们评估了381例HTx术后存活至少1年的患者,并使用肾脏病饮食改良研究公式计算估算的GFR。将死亡率和血管造影CAV定义为单独的终点,中位随访时间分别为7.4年和4.0年。
在随访期间,122例患者死亡,154例患者发生CAV。HTx术前GFR降低不是任何一个终点的危险因素。总体而言,193例(51%)患者在HTx术后1年GFR<60 ml/min/1.73 m²,这是全因死亡率的独立预测因素,GFR在30 - 60之间时调整后风险比为1.7(P = 0.01),GFR<30 ml/min/1.73 m²时为3.2(P = 0.006)。HTx术后1年GFR<60 ml/min/1.73 m²也与心脏死亡率较高相关(HR = 1.9;P = 0.04),但不能预测CAV的发生。
大多数HTx受者在HTx术后1年出现肾功能损害。它是全因死亡率和心脏死亡率的重要危险因素,但不能预测血管造影CAV的发生。